Dexcom, Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, Dexcom, Inc. reported total assets of $6.34B and shareholders' equity of $2.75B. That works out to liabilities equal to 57% of assets, a current ratio of 1.88 (current assets ÷ current liabilities).
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $402.80M | $904.10M | $1.92B | $2.40B | $4.29B | $4.93B | $5.39B | $6.26B | $6.48B | $6.34B |
| Current assets | $280.00M | $744.70M | $1.70B | $1.97B | $3.42B | $3.68B | $3.67B | $4.43B | $4.30B | $4.03B |
| Cash & equivalents | $94.50M | $441.50M | $1.14B | $446.20M | $817.60M | $1.05B | $642.30M | $566.30M | $606.10M | $917.70M |
| Total liabilities | $119.00M | $484.70M | $1.25B | $1.51B | $2.46B | $2.89B | $3.26B | $4.20B | $4.38B | $3.59B |
| Current liabilities | $102.40M | $138.90M | $222.40M | $360.20M | $614.10M | $720.80M | $1.84B | $1.56B | $2.93B | $2.14B |
| Shareholders' equity | $283.80M | $419.40M | $663.30M | $882.60M | $1.55B | $2.04B | $2.13B | $2.07B | $2.10B | $2.75B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 1093557 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.